Advertisement

Reactions Weekly

, Volume 1696, Issue 1, pp 214–214 | Cite as

Ipilimumab/nivolumab

Enteritis and hepatitis: case report
Case report
  • 20 Downloads

Reference

  1. Diana P, et al. Emerging role of vedolizumab in managing refractory immune checkpoint inhibitor-induced enteritis. ACG Case Reports Journal 5: No. 5, Feb 2018. Available from: URL: http://doi.org/10.14309/crj.2018.17 - Italy

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Personalised recommendations